 Tests carried out in combination with chemotherapy drugs achieved almost complete remission in mice .
The US scientists used low doses of the drug oxaliplatin , which has a unique ability to activate cancer-killing immune cells in small tumours .
Each year in the UK around 41,000 men are diagnosed with prostate cancer and 11,000 die from the disease .